| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, NY
Canine osteosarcoma (OS) has been used as a model system for the study of cancer biology and treatment despite the lack of information regarding its pathogenesis. Expression of tumor suppressor genes known to participate in malignant transformation were studied in five different OS cell lines. Each of the cell lines exhibited properties of transformed cells, and those that were tested grew in soft agarose and formed osteoid-containing tumors when injected subcutaneously into nude mice. p53 function was determined to be defective in each cell line as indicated by the lack of induction of p53-responsive genes, p21 and mdm2, following treatment with 5-fluorouracil. p53 mRNA and protein levels were elevated in three cell lines and were extremely low in two cell lines. p53 protein overexpression correlated with the presence of mutations within the DNA binding domain. Four cell lines appeared to contain normal retinoblastoma (Rb) mRNA and Rb protein and no detectable p16 mRNA or protein. In contrast, the remaining cell line contained high levels of p16 mRNA and protein and significantly reduced levels of Rb, p107, and p130 proteins. These results underscore the importance of inactivating p53 and Rb family pathways in canine OS and suggest that unlike human OS, cells derived from canine OS contain mutations that simultaneously inactivate all three Rb family members.
Key words: Bone neoplasia; dogs; osteosarcoma; p53; retinoblastoma; tumorigenesis.
Request reprints from Dr. Roy Levine, Department of Molecular Medicine (VMC C4-171), College of Veterinary Medicine, Cornell University, Ithaca, NY 14853 (USA). E-mail: rall{at}cornell.edu.
This article has been cited by other articles:
 |
|
 |
|
  P. Loukopoulos, J. R. Thornton, and W. F. Robinson Clinical and Pathologic Relevance of p53 Index in Canine Osseous Tumors Vet. Pathol., May 1, 2003; 40(3): 237 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Koenig, S. R. Bianco, S. Fosmire, J. Wojcieszyn, and J. F. Modiano Expression and Significance of p53, Rb, p21/waf-1, p16/ink-4a, and PTEN Tumor Suppressors in Canine Melanoma Vet. Pathol., July 1, 2002; 39(4): 458 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Levine, T. Forest, and C. Smith Tumor Suppressor PTEN is Mutated in Canine Osteosarcoma Cell Lines and Tumors Vet. Pathol., May 1, 2002; 39(3): 372 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Levine Overexpression of the Sis Oncogene in a Canine Osteosarcoma Cell Line Vet. Pathol., May 1, 2002; 39(3): 411 - 412. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
